surpass 5 tirzepatide Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial Tirzepatide Significantly Reduced A1C and

Semaglutide is the first drug approved by the Food and Drug Administration (FDA) for chronic weight management/weight loss since 2014 and is marketed under brand names such as Ozempic, Wegovy, and a few other names

Antioxidant Protection: As a powerful antioxidant, glutathione protects skin cells from UV exposure and free radical damage

Saxenda 6 mg/ml solution for injection in pre-filled pen

Another purported function of vitamin C on the skin is that it promotes the production of collagen

The medication provides the appetite suppression and metabolic benefits

The Source: This article includes information from Eli Lilly, The New York Times and previous FOX Local reporting.